A recent study showed that the activated estrogen receptor can suppress the expression of BAX by up-regulating a group of miRNAs including hsa-let-7 family members in endometrial adenocarcinoma and precancerous lesions [47]. This evidence concerns the gene ESR1 and endometrium adenocarcinoma.